Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DURECT Corp (NASDAQ:DRRX)

1.24
Delayed Data
As of 12:01pm ET
 -0.0299 / -2.35%
Today’s Change
0.99
Today|||52-Week Range
2.00
-7.46%
Year-to-Date
No recent news for DURECT Corp.

Today’s Trading

Previous close1.27
Today’s open1.26
Day’s range1.22 - 1.26
Volume136,589
Average volume (3 months)814,489
Market cap$176.0M
Dividend yield--
Data as of 12:01pm ET, 01/17/2017

Growth & Valuation

Earnings growth (last year)+5.00%
Earnings growth (this year)-38.60%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-1.43%
P/E ratioNM
Price/Sales13.70
Price/Book10.40

Competitors

 Today’s
change
Today’s
% change
CEMPCempra Inc-0.17-5.15%
--China Health Group I...0.000.00%
OPHTOphthotech Corp-0.14-2.88%
RDHLRedhill Biopharma Lt...-0.22-2.09%
Data as of 12:17pm ET, 01/17/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$19.1M
Annual profit (last year)-$22.7M
Net profit margin-118.51%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Scientific Officer
Felix Theeuwes
President, Chief Executive Officer &
Director
James E. Brown
Corporate headquarters
Cupertino, California

Forecasts


Search for Jobs